Formulation, in vitro, and in vivo evaluation of matrix-type transdermal patches containing olanzapine

References

• Samanta MK, Dube R, Suresh B. Transdermal drug delivery system of haloperidol to overcome self-induced extrapyramidal syndrome. Drug Dev Ind Pharm 2003;29:405–415.
   PubMed Web of Science ®Google Scholar
• Branford D. (2003). Schizophrenia. In: Walker R, Edwards C, eds. Clinical Pharmacy and Therapeutics. 3rd ed., London: Churchill Livingstone, 459–460.
   Google Scholar
• Mortimer AM, Al-Agib AO. Quality of life in schizophrenia on conventional versus atypical antipsychotic medication: A comparative cross-sectional study. Int J Soc Psychiatry 2007;53:99–107.
   PubMed Web of Science ®Google Scholar
• Stahl SM, Grady MM. A critical review of atypical antipsychotic utilization: Comparing monotherapy with polypharmacy and augmentation. Curr Med Chem 2004;11:313–327.
   PubMed Web of Science ®Google Scholar
• Wertheimer AI, Santella TM, Finestone AJ, Levy RA. Drug delivery systems improve pharmaceutical profile and facilitate medication adherence. Adv Ther 2005;22:559–577.
   PubMed Web of Science ®Google Scholar
• Parikh DK, Ghosh TK. Feasibility of transdermal delivery of fluoxetine. AAPS PharmSciTech 2005;6:E144–E149.
   PubMedGoogle Scholar
• Gordon RD, Peterson TA. Four myths about transdermal drug delivery. Drug Deliv Technol 2003;3:1–7.
   Google Scholar
• Gordon R. Olanzapine containing transdermal drug delivery compositions. WO/2005/ 049090.
   Google Scholar
• Sharma S, Aggarwal G, Dhawan S. Design and evaluation of olanzapine transdermal patches containing vegetable oils as permeation enhancers. Der Pharmacia Lettre 2010;2:84–98.
   Google Scholar
• Nokhodchi A, Shokri J, Dashbolaghi A, Hassan-Zadeh D, Ghafourian T, Barzegar-Jalali M. The enhancement effect of surfactants on the penetration of lorazepam through rat skin. Int J Pharm 2003;250:359–369.
   PubMed Web of Science ®Google Scholar
• Charoo NA, Anwer A, Kohli K, Pillai KK, Rahman Z. Transdermal delivery of flurbiprofen: Permeation enhancement, design, pharmacokinetic, and pharmacodynamic studies in albino rats. Pharm Dev Technol 2005;10:343–351.
   PubMed Web of Science ®Google Scholar
• Verma PRP, Iyer S. Transdermal delivery of propranolol using mixed grades of eudragit: Design and in vitro and in vivo evaluation. Drug Develop Ind Pharm 2000;26:471–476.
   PubMed Web of Science ®Google Scholar
• Pradnya B Patil PB, Gupta VRM, Udupi RH, SrikanthK Prasad, BSG. Development of dissolution medium for poorly water soluble drug mefenamic acid. Research J Pharma Bio Chemical Sci 2010;1:544–549.
   Google Scholar
• Lewis S, Pandey S, Udupa N. Design and evaluation of matrix type and membrane controlled transdermal delivery systems of nicotine suitable for use in smoking cessation. Ind J Pharm Sci 2006;68:179–184.
   Google Scholar
• Ubaidulla U, Reddy MV, Ruckmani K, Ahmad FJ, Khar RK. Transdermal therapeutic system of carvedilol: Effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics. AAPS PharmSciTech 2007;8:2.
   PubMed Web of Science ®Google Scholar
• Baichwal MR. (1985). Polymer films as drug delivery systems. In: Advances in drug delivery systems. Bombay: MSR Foundation, 136–147.
   Google Scholar
• Bagyalakshmi J, Vamsikrishna RP, Manavalan R, Ravi TK, Manna PK. Formulation development and in vitro and in vivo evaluation of membrane-moderated transdermal systems of ampicillin sodium in ethanol: pH 4.7 buffer solvent system. AAPS PharmSciTech 2007;8:7.
   PubMed Web of Science ®Google Scholar
• Tymes NW, Shah VP, Skelly JP. In vitro release profile of estradiol transdermal therapeutic systems. J Pharm Sci 1990;79:601–602.
   PubMed Web of Science ®Google Scholar
• Alam MI, Baboota S, Kohli K, Ali J, Ahuja A. Development and evaluation of transdermal patches of celecoxib. PDA J Pharm Sci Technol 2009;63:429–437.
   PubMedGoogle Scholar
• Mundargi RC, Patil SA, Agnihotri SA, Aminabhavi TM. Evaluation and controlled release characteristics of modified xanthan films for transdermal delivery of atenolol. Drug Dev Ind Pharm 2007;33:79–90.
   PubMed Web of Science ®Google Scholar
• Kirwin CJ. Eye and skin local toxicity testing. In: Sperling F, eds. Toxicology: Principles and practice. Vol 2, Wiley-Interscience publication; 1984:169–175.
   Google Scholar
• Mutalik S, Udupa N. Formulation development, in vitro and in vivo evaluation of membrane controlled transdermal systems of glibenclamide. J Pharm Pharm Sci 2005;8:26–38.
   PubMed Web of Science ®Google Scholar
• Zhang G, Terry AV Jr, Bartlett MG. Simultaneous determination of five antipsychotic drugs in rat plasma by high performance liquid chromatography with ultraviolet detection. J Chromatogr B Analyt Technol Biomed Life Sci 2007;856:20–28.
   PubMed Web of Science ®Google Scholar
• Dusci LJ, Peter Hackett L, Fellows LM, Ilett KF. Determination of olanzapine in plasma by high-performance liquid chromatography using ultraviolet absorbance detection. J Chromatogr B Analyt Technol Biomed Life Sci 2002;773:191–197.
   PubMed Web of Science ®Google Scholar
• Sun Y, Fang L, Zhu M, Li W, Meng P, Li L et al. A drug-in-adhesive transdermal patch for S-amlodipine free base: In vitro and in vivo characterization. Int J Pharm 2009;382:165–171.
   PubMed Web of Science ®Google Scholar
• Bauerová K, Matusová D, Kassai Z. Chemical enhancers for transdermal drug transport. Eur J Drug Metab Pharmacokinet 2001;26:85–94.
   PubMedGoogle Scholar
• Budhathoki U, Thapa P. Effect of chemical enhancers on in vitro release of salbutamol sulfate from transdermal patches. Kathmandu University of Science Engineering and Technology 2005;1:1–8.
   Google Scholar
• Mukherjee B, Kanupriya Mahapatra, S, Das S, Patra B. Sorbitan monolaurate 20 as a potential skin permeation enhancer in transdermal patches. J Applied Research 2005;5:96–107.
   Google Scholar
• Sanap GS, Dama GY, Hande AS, Karpe SP, Nalawade SV, Kakade RS, Jadhav UY. Prepration of transdermal monolithic systems of indapamide by solvent casting method and the use of vegetable oils as permeation enhancer. Int J Green pharmacy 2008;2:129–133.
   Google Scholar
• Jain R, Aqil M, Ahad A, Ali A, Khar RK. Basil oil is a promising skin penetration enhancer for transdermal delivery of labetolol hydrochloride. Drug Dev Ind Pharm 2008;34:384–389.
   PubMed Web of Science ®Google Scholar
• Chandak AR, Verma PRP. Development and evaluation of HPMC based matrices for transdermal patches of tramadol. Clinical Res Regulatory Affairs 2008;25:13–30.
   Google Scholar
• Merchant HA, Shoaib HM, Tazeen J, Yousuf R. Once-daily tablet formulation and in vitro release evaluation of cefpodoxime using hydroxypropyl methylcellulose: A technical note. AAPS PharmSciTech 2006;7:78.
   PubMed Web of Science ®Google Scholar
• Mittal A, Sara US, Ali A, Mohammed A. Design, development, physicochemical, in vitro and in vivo evaluation of monolithic matrix type transdermal patches containing nitrendipine. Pharm Dev Technol 2009;14:422–434.
   PubMed Web of Science ®Google Scholar
• Li L, Fang L, Xu X, Liu Y, Sun Y, He Z. Formulation and biopharmaceutical evaluation of a transdermal patch containing letrozole. Biopharm Drug Dispos 2010;31:138–149.
   PubMed Web of Science ®Google Scholar
• Shamsher AA, Charoo NA, Kohli K, Pillai K, Rahman Z. Effect of transdermally delivered aspirin on blood coagulation parameters. Am J Biomed Sci 2010;2:129–141.
   Google Scholar
• Iman IS, Nadia AS, Ebtsan MA. Fomulation and stability study of chlorpheniramine maleate transdermal patch. Asian J Pharm 2010;4:17–22.
   Google Scholar
• Costa P, Ferriera DC, Morgado R, Lobo JMS. Design and evaluation of a lorazepam transdermal delivery system. Drug Dev Ind Pharm 1997;23:939–944.
   Web of Science ®Google Scholar
• Samip SS, Joshi R, Prabhu P. Formulation and evaluation of transdermal patches of papaverine hydrochloride. Asian J Pharm 2010;4:79–86.
   Google Scholar